California State Teachers Retirement System Iovance Biotherapeutics, Inc. Transaction History

California State Teachers Retirement System

  • $84.1 Billion
  • Q3 2024

A detailed history of California State Teachers Retirement System transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 189,467 shares of IOVA stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
189,467
Previous 195,180 2.93%
Holding current value
$1.54 Million
Previous $1.57 Million 13.67%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$7.28 - $11.9 $41,590 - $67,984
-5,713 Reduced 2.93%
189,467 $1.78 Million
Q2 2024

Aug 14, 2024
SELL
$7.78 - $14.19 $9,966 - $18,177
-1,281 Reduced 0.65%
195,180 $1.57 Million
Q1 2024

May 15, 2024
SELL
$7.59 - $17.47 $302,818 - $697,000
-39,897 Reduced 16.88%
196,461 $2.91 Million
Q4 2023

Feb 13, 2024
SELL
$3.3 - $8.89 $36,210 - $97,549
-10,973 Reduced 4.44%
236,358 $1.92 Million
Q3 2023

Nov 14, 2023
BUY
$4.44 - $8.79 $52,205 - $103,352
11,758 Added 4.99%
247,331 $1.13 Million
Q2 2023

Aug 21, 2023
BUY
$5.36 - $9.06 $404,781 - $684,202
75,519 Added 47.18%
235,573 $1.66 Million
Q1 2023

May 09, 2023
SELL
$5.53 - $8.22 $16,330 - $24,273
-2,953 Reduced 1.81%
160,054 $977,000
Q4 2022

Feb 14, 2023
BUY
$5.62 - $10.0 $11,431 - $20,340
2,034 Added 1.26%
163,007 $1.04 Million
Q3 2022

Nov 18, 2022
SELL
$9.53 - $13.11 $37,776 - $51,968
-3,964 Reduced 2.4%
160,973 $1.54 Million
Q2 2022

Aug 15, 2022
SELL
$6.38 - $18.33 $42,809 - $122,994
-6,710 Reduced 3.91%
164,937 $1.82 Million
Q1 2022

May 16, 2022
SELL
$12.38 - $19.1 $186,863 - $288,295
-15,094 Reduced 8.08%
171,647 $2.86 Million
Q4 2021

Feb 15, 2022
SELL
$16.55 - $27.63 $665,674 - $1.11 Million
-40,222 Reduced 17.72%
186,741 $3.57 Million
Q3 2021

Nov 15, 2021
SELL
$20.35 - $26.63 $445,013 - $582,344
-21,868 Reduced 8.79%
226,963 $5.6 Million
Q2 2021

Aug 16, 2021
BUY
$16.33 - $33.07 $28,005 - $56,715
1,715 Added 0.69%
248,831 $6.48 Million
Q1 2021

May 18, 2021
SELL
$28.67 - $52.59 $29,530 - $54,167
-1,030 Reduced 0.42%
247,116 $7.82 Million
Q4 2020

Feb 16, 2021
BUY
$28.04 - $50.26 $143,676 - $257,532
5,124 Added 2.11%
248,146 $11.5 Million
Q3 2020

Nov 17, 2020
BUY
$27.75 - $36.3 $281,690 - $368,481
10,151 Added 4.36%
243,022 $8 Million
Q2 2020

Aug 17, 2020
BUY
$27.21 - $41.0 $1.49 Million - $2.25 Million
54,793 Added 30.77%
232,871 $6.39 Million
Q1 2020

May 13, 2020
SELL
$19.54 - $38.85 $17,253 - $34,304
-883 Reduced 0.49%
178,078 $5.33 Million
Q4 2019

Feb 14, 2020
BUY
$17.95 - $29.41 $4,720 - $7,734
263 Added 0.15%
178,961 $4.95 Million
Q3 2019

Nov 15, 2019
BUY
$17.99 - $26.0 $38,390 - $55,484
2,134 Added 1.21%
178,698 $3.25 Million
Q2 2019

Aug 14, 2019
BUY
$9.78 - $24.52 $129,800 - $325,429
13,272 Added 8.13%
176,564 $4.33 Million
Q1 2019

May 09, 2019
SELL
$8.41 - $11.26 $20,352 - $27,249
-2,420 Reduced 1.46%
163,292 $1.55 Million
Q4 2018

Feb 13, 2019
BUY
$7.51 - $11.93 $299,558 - $475,863
39,888 Added 31.7%
165,712 $1.47 Million
Q3 2018

Nov 14, 2018
BUY
$11.25 - $17.7 $787 - $1,239
70 Added 0.06%
125,824 $1.42 Million
Q2 2018

Aug 14, 2018
BUY
$12.45 - $16.95 $168,174 - $228,960
13,508 Added 12.03%
125,754 $1.61 Million
Q1 2018

May 15, 2018
BUY
$8.1 - $19.5 $123,136 - $296,439
15,202 Added 15.67%
112,246 $1.9 Million
Q4 2017

Feb 14, 2018
BUY
$6.65 - $9.25 $76,867 - $106,920
11,559 Added 13.52%
97,044 $776,000
Q3 2017

Nov 13, 2017
BUY
$4.45 - $8.55 $380,408 - $730,896
85,485
85,485 $663,000

Others Institutions Holding IOVA

# of Institutions
313
Shares Held
241M
Call Options Held
3.77M
Put Options Held
1.7M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email